Vertex Pharmaceuticals (VRTX) Profit After Tax Growth (3y) (2012 - 2026)
Vertex Pharmaceuticals (VRTX) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 33.21% |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 30.60% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | -154.28% |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | 16.53% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 13.80% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | -3.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.80% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 5.19% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -5.35% |
| Dec 31, 2024 | 5.84% |
| Sep 30, 2024 | 7.06% |
| Jun 30, 2024 | -281.76% |
| Mar 31, 2024 | 18.96% |
| Dec 31, 2023 | 17.05% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 3.03% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | 11.98% |
| Sep 30, 2022 | 152.91% |
| Jun 30, 2022 | 44.72% |
| Mar 31, 2022 | 41.56% |
| Dec 31, 2021 | -20.81% |
| Sep 30, 2021 | 87.74% |
| Jun 30, 2021 | -31.38% |